The Global En Bloc Resection of Bladder Tumour Registry
ConditionBladder Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong
About this trial
The study aims to collect data on ERBT globally in order to clarify its role in the management of bladder cancer over a 5-year observation period.
Eligibility criteria
Qualifiers
Adult patients >=18 years old with informed consent
Presence of bladder tumour undergoing transurethral ERBT
Disqualifiers
Presence or previous history of upper tract urothelial carcinoma
Presence of other active malignancy
Pregnancy
Trial design
Treatments tested in this trial
- En bloc resection of bladder tumour
Treatment groups
2,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov